Generics Seen Slashing Global Pharma Drug Sales Growth, According to IMS Health

Global sales growth of prescription drugs could be cut in half over the next five years as lucrative brands lose patent protection and cheaper generics and emerging markets become the only significant growth drivers, according to IMS Health.

Back to news